Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Iazsmin Bauer Ventura"'
Autor:
Flavia V Castelino, Brent P. Little, Amita Sharma, Sydney B. Montesi, Hyon K. Choi, Mary E. Strek, Iazsmin Bauer Ventura, Ayodeji Adegunsoye, Marcy B. Bolster, Kristin M. D’Silva
Publikováno v:
Rheumatology Advances in Practice
Objectives Many patients with interstitial lung disease (ILD) have autoimmune manifestations but do not meet criteria for a systemic rheumatic disease. A subset meets criteria for interstitial pneumonia with autoimmune features (IPAF) and have ILD re
Publikováno v:
Annals of the American Thoracic Society
Autor:
Harold R. Collard, Natalia Achtar-Zadeh, Gabrielle Y. Liu, Paul J. Wolters, Brett Ley, Ayodeji Adegunsoye, Kirk D. Jones, Mary E. Strek, Iazsmin Bauer Ventura, Brett M. Elicker
Publikováno v:
Chest. 156:715-723
Background Antineutrophil cytoplasmic antibodies (ANCAs) have been reported to occur in 7% to 10% of patients with idiopathic pulmonary fibrosis (IPF), but their clinical relevance remains unclear. The aim of this study was to estimate the prevalence
Autor:
Rachel Strykowski, Robert D. Guzy, Cathryn Lee, R. Jablonski, Rekha Vij, Iazsmin Bauer Ventura, Ayodeji Adegunsoye, Nicole Garcia, Mary E. Strek, Jonathan H. Chung, Albina Tyker
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Rheumatoid arthritis-related interstitial lung disease (RA-ILD) is a common connective tissue disease-related ILD (CTD-ILD) associated with high morbidity and mortality. Although rheumatoid factor (RF) seropositivity is a risk factor for developing R
Autor:
Mary E. Strek, Cathryn Lee, R. Jablonski, Maria Poonawalla, Jonathan H. Chung, Iazsmin Bauer Ventura, Ayodeji Adegunsoye, Rekha Vij, Nicole Garcia, Rachel Strykowski, Robert D. Guzy, Albina Tyker
Background: The impact of the SARS-CoV-2 virus on patients with interstitial lung disease (ILD) remains poorly understood. As patients with ILD often have severe underlying lung parenchymal involvement, and immunosuppressive therapy is common in this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36d949217fabb027305b1ed2d2a997b4
https://doi.org/10.21203/rs.3.rs-913501/v1
https://doi.org/10.21203/rs.3.rs-913501/v1
Autor:
Bhakti K. Patel, Alec Kacew, Garth W. Strohbehn, Brian L. Heiss, Alexandra Cabanov, Keith Danahey, Thomas F. Gajewski, Natasha N Pettit, Rachel C Wright, Jennifer Pisano, Emily F. Higgs, Mark J. Ratain, Jeffrey Bloodworth, Cuoghi Edens, Pankti Reid, Jovian Yu, Iazsmin Bauer Ventura, Mary E. Strek, Theodore Karrison, Adriana Koziol, Jonathan A. Trujillo, Sherin J. Rouhani, Alexandra Weiss
Publikováno v:
Clinical Pharmacology & Therapeutics
medRxiv
medRxiv
Background Interleukin-6 (IL-6)-mediated hyperinflammation may contribute to the high mortality of coronavirus disease 2019 (Covid-19). Tocilizumab, an IL-6 receptor blocking monoclonal antibody, has been repurposed for Covid-19, but prospective tria
Autor:
Cuoghi Edens, Pankti Reid, Rachel C Wright, Iazsmin Bauer Ventura, Jonathan A. Trujillo, Jennifer Pisano, Bhakti K. Patel, Mark J. Ratain, Keith Danahey, Mary E. Strek, Natasha N Pettit, Thomas F. Gajewski, Alexandra Cabanov, Sherin J. Rouhani, Garth W. Strohbehn, Jovian Yu, Brian L. Heiss, Theodore Karrison, Adriana Koziol, Emily F. Higgs, Alec Kacew, Jeffrey Bloodworth, Alexandra Weiss
Publikováno v:
Clinical Pharmacology and Therapeutics
BackgroundInterleukin-6 (IL-6)-mediated hyperinflammation may contribute to the high mortality of coronavirus disease 2019 (Covid-19). Tocilizumab, an IL-6 receptor blocking monoclonal antibody, has been repurposed for Covid-19, but prospective trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::780ec8d6bde20cab19021335fa6bdf14
Autor:
Jonathan H. Chung, Mary E. Strek, Stella E. Hines, Rekha Vij, Ayodeji Adegunsoye, Iazsmin Bauer Ventura, Cathryn Lee, R. Jablonski, Steven M. Montner
Publikováno v:
Chest
BACKGROUND: Inhalational exposures are increasingly recognized as contributing factors in interstitial lung disease (ILD). However, the characteristics of both exposures and exposed patients are not well understood. We hypothesized that domestic and
Autor:
Cathryn Lee, Christine Kim Garcia, Janelle Vu Pugashetti, Chad A. Newton, J. Graham, Mary E. Strek, Claire Cutting, Michael A. Kadoch, Imre Noth, Iazsmin Bauer Ventura, Noelle Boctor, Elena K. Joerns, Ayodeji Adegunsoye, Jonathan H. Chung, Habrinder Sandhu, Justin M. Oldham
Publikováno v:
Eur Respir J
Interstitial pneumonia with autoimmune features (IPAF) characterises individuals with interstitial lung disease (ILD) and features of connective tissue disease (CTD) who fail to satisfy CTD criteria. Inclusion of myositis-specific antibodies (MSAs) i
Autor:
R. Jablonski, Iazsmin Bauer Ventura, Mary E. Strek, Ayodeji Adegunsoye, Eleanor Phillips, Cathryn Lee
Publikováno v:
Chest. 158:A1074-A1075